May 8, 2018 / 8:54 PM / 6 months ago

BRIEF-Revance Reports Qtrly Loss Per Share $0.97

May 8 (Reuters) - Revance Therapeutics Inc:

* Q1 REVENUE $200,000 VERSUS $100,000

* Q1 REVENUE VIEW $5.1 MILLION -- THOMSON REUTERS I/B/E/S

* QTRLY LOSS PER SHARE $0.97

* REITERATES ITS FINANCIAL GUIDANCE PROVIDED IN JANUARY 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below